{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,27]],"date-time":"2026-01-27T19:47:15Z","timestamp":1769543235410,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","valueinhealthjournal.com","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jval.2017.05.019","type":"journal-article","created":{"date-parts":[[2017,7,11]],"date-time":"2017-07-11T23:46:38Z","timestamp":1499816798000},"page":"1252-1259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study"],"prefix":"10.1016","volume":"20","author":[{"given":"Lee","family":"Brekke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erin","family":"Buysman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Grabner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuehua","family":"Ke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Onur","family":"Baser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenhui","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jval.2017.05.019_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jval.2017.05.019_bib2","doi-asserted-by":"crossref","first-page":"536","DOI":"10.4158\/EP13176.CS","article-title":"American Association of Clinical Endocrinologists\u2019 comprehensive diabetes management algorithm 2013 consensus statement\u2014executive summary","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jval.2017.05.019_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.4158\/EP15693.CS","article-title":"AACE\/ACE comprehensive diabetes management algorithm 2015","volume":"21","author":"Garber","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jval.2017.05.019_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.2217\/cer.12.23","article-title":"Building useful evidence: changing the clinical research paradigm to account for comparative effectiveness research","volume":"1","author":"Greenfield","year":"2012","journal-title":"J Comp Eff Res"},{"key":"10.1016\/j.jval.2017.05.019_bib5","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2307\/144855","article-title":"Wage discrimination: reduced form and structural estimates","volume":"8","author":"Blinder","year":"1973","journal-title":"J Hum Resour"},{"key":"10.1016\/j.jval.2017.05.019_bib6","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2307\/2525981","article-title":"Male-female wage differentials in urban labor markets","volume":"14","author":"Oaxaca","year":"1973","journal-title":"Int Econ Rev"},{"key":"10.1016\/j.jval.2017.05.019_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/1536867X0800800401","article-title":"The Blinder-Oaxaca decomposition for linear regression models","volume":"8","author":"Jann","year":"2008","journal-title":"Stata J"},{"key":"10.1016\/j.jval.2017.05.019_bib8","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1177\/1536867X0800800402","article-title":"The Blinder-Oaxaca decomposition for nonlinear regression models","volume":"8","author":"Sinning","year":"2008","journal-title":"Stata J"},{"key":"10.1016\/j.jval.2017.05.019_bib9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1177\/1536867X1101100404","article-title":"mvdcmp: multivariate decomposition for nonlinear response models","volume":"11","author":"Powers","year":"2011","journal-title":"Stata J"},{"key":"10.1016\/j.jval.2017.05.019_bib10","unstructured":"Crown WH, Olson WH. Using decomposition methods to estimate heterogeneity of treatment effects in randomized trials and observational studies. Available from: https:\/\/www.ispor.org\/congresses\/Berlin1112\/presentations\/W1_OlsonCrown.pdf. [Accessed May 24, 2016]."},{"key":"10.1016\/j.jval.2017.05.019_bib11","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00125-009-1472-y","article-title":"Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial","volume":"52","author":"Russell-Jones","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/j.jval.2017.05.019_bib12","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1007\/s12325-013-0074-8","article-title":"The INITIATOR study: pilot data on real-world clinical and economic outcomes in US patients with type 2 diabetes initiating injectable therapy","volume":"30","author":"Thayer","year":"2013","journal-title":"Adv Ther"},{"key":"10.1016\/j.jval.2017.05.019_bib13","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1111\/dom.12828","article-title":"A real-world study of treatment patterns and outcomes in US managed-care patients with type 2 diabetes initiating injectable therapies","volume":"19","author":"Wei","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/j.jval.2017.05.019_bib14","unstructured":"Centers for Disease Control and Prevention. International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM). Available from: http:\/\/www.cdc.gov\/nchs\/icd\/icd9cm.htm. [Accessed May 24, 2016]."},{"key":"10.1016\/j.jval.2017.05.019_bib15","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4158\/EP13159.OR","article-title":"Real-world insulin treatment persistence among patients with type 2 diabetes","volume":"20","author":"Wei","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/j.jval.2017.05.019_bib16","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.econlet.2003.09.008","article-title":"Decomposing differences in the first moment","volume":"82","author":"Yun","year":"2004","journal-title":"Econ Lett"},{"key":"10.1016\/j.jval.2017.05.019_bib17","series-title":"SAS\u00ae 9.3 System Options: Reference","year":"2011"},{"key":"10.1016\/j.jval.2017.05.019_bib18","series-title":"Stata: Release 13","author":"StataCorp","year":"2013"},{"key":"10.1016\/j.jval.2017.05.019_bib19","first-page":"e6497","article-title":"Decomposing the gap in childhood undernutrition between poor and non-poor in urban India, 2005\u20136","volume":"8","author":"Kumar","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2017.05.019_bib20","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/1475-9276-11-52","article-title":"Social determinants of sex differences in disability among older adults: a multi-country decomposition analysis using the World Health Survey","volume":"11","author":"Hosseinpoor","year":"2012","journal-title":"Int J Equity Health"},{"key":"10.1016\/j.jval.2017.05.019_bib21","doi-asserted-by":"crossref","first-page":"e34799","DOI":"10.1371\/journal.pone.0034799","article-title":"Social determinants of self reported health in women and men: understanding the role of gender in population health","volume":"7","author":"Hosseinpoor","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.jval.2017.05.019_bib22","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1186\/1471-2458-12-390","article-title":"\u201cHealth divide\u201d between indigenous and non-indigenous populations in Kerala, India: population based study","volume":"12","author":"Haddad","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/j.jval.2017.05.019_bib23","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1097\/MLR.0b013e3181eb31d2","article-title":"A comparison of health care in Canada and the US\u2014the case of pap smears","volume":"48","author":"Gohmann","year":"2010","journal-title":"Med Care"},{"key":"10.1016\/j.jval.2017.05.019_bib24","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1093\/aje\/kwr050","article-title":"The gap of visual impairment between economic groups in Shahroud, Iran: a Blinder-Oaxaca decomposition","volume":"173","author":"Emamian","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.jval.2017.05.019_bib25","doi-asserted-by":"crossref","first-page":"307","DOI":"10.15171\/ijhpm.2014.100","article-title":"Economic inequality in eye care utilization and its determinants: a Blinder-Oaxaca decomposition","volume":"3","author":"Emamian","year":"2014","journal-title":"Int J Health Policy Manag"},{"key":"10.1016\/j.jval.2017.05.019_bib26","first-page":"e17602","article-title":"Socioeconomic inequality and its determinants regarding infant mortality in Iran","volume":"16","author":"Damghanian","year":"2014","journal-title":"Iran Red Crescent Med J"},{"key":"10.1016\/j.jval.2017.05.019_bib27","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1472-6963-11-116","article-title":"The evolution of health status and chronic conditions in Catalonia, 1994\u20132006: the paradox of health revisited using the Blinder-Oaxaca decomposition","volume":"11","author":"Garc\u00eda-Alt\u00e9s","year":"2011","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.jval.2017.05.019_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1007\/s10903-010-9406-9","article-title":"Variations in healthcare access and utilization among Mexican immigrants: the role of documentation status","volume":"14","author":"Bustamante","year":"2012","journal-title":"J Immigr Minor Health"},{"key":"10.1016\/j.jval.2017.05.019_bib29","doi-asserted-by":"crossref","first-page":"178","DOI":"10.3390\/ijerph10010178","article-title":"Health insurance, socio-economic position and racial disparities in preventive dental visits in South Africa","volume":"10","author":"Ayo-Yusuf","year":"2013","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.jval.2017.05.019_bib30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.2147\/COPD.S59139","article-title":"Explaining the increased health care expenditures associated with gastroesophageal reflux disease among elderly Medicare beneficiaries with chronic obstructive pulmonary disease: a cost-decomposition analysis","volume":"9","author":"Ajmera","year":"2014","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"10.1016\/j.jval.2017.05.019_bib31","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1002\/oby.20285","article-title":"Variations between obese Latinos and whites in weight-related counseling during preventive clinical visits in the United States","volume":"21","author":"Ma","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/j.jval.2017.05.019_bib32","doi-asserted-by":"crossref","first-page":"947","DOI":"10.2165\/11537750-000000000-00000","article-title":"There\u2019s a reason they call them dummy variables: a note on the use of structural equation techniques in comparative effectiveness research","volume":"28","author":"Crown","year":"2010","journal-title":"Pharmacoeconomics"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301517302723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1098301517302723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T01:09:03Z","timestamp":1550106543000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1098301517302723"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":32,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S1098301517302723"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2017.05.019","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Use of Decomposition Methods in Real-World Treatment Benefits Evaluation for Patients with Type 2 Diabetes Initiating Different Injectable Therapies: Findings from the INITIATOR Study","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2017.05.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}